Journal of Experimental & Clinical Cancer Research (Sep 2024)
Correction: Novel engineered IL-2 Nemvaleukin alfa combined with PD1 checkpoint blockade enhances the systemic anti-tumor responses of radiation therapy
- Kewen He,
- Nahum Puebla-Osorio,
- Hampartsoum B. Barsoumian,
- Duygu Sezen,
- Zahid Rafq,
- Thomas S. Riad,
- Yun Hu,
- Ailing Huang,
- Tifany A. Voss,
- Claudia S. Kettlun Leyton,
- Lily Jae Schuda,
- Ethan Hsu,
- Joshua Heiber,
- Maria-Angelica Cortez,
- James W. Welsh
Affiliations
- Kewen He
- Department of Radiation Oncology, Shandong First Medical University and Shandong Academy of Medical Sciences, Shandong Cancer Hospital and Institute
- Nahum Puebla-Osorio
- Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center
- Hampartsoum B. Barsoumian
- Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center
- Duygu Sezen
- Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center
- Zahid Rafq
- Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center
- Thomas S. Riad
- Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center
- Yun Hu
- Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center
- Ailing Huang
- Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center
- Tifany A. Voss
- Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center
- Claudia S. Kettlun Leyton
- Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center
- Lily Jae Schuda
- Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center
- Ethan Hsu
- Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center
- Joshua Heiber
- Mural Oncology PLC
- Maria-Angelica Cortez
- Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center
- James W. Welsh
- Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center
- DOI
- https://doi.org/10.1186/s13046-024-03183-9
- Journal volume & issue
-
Vol. 43,
no. 1
pp. 1 – 1
Abstract
No abstracts available.
